-
1
-
-
0023666065
-
Integrins: A family of cell surface receptors
-
Hynes RO. Integrins: A family of cell surface receptors. Cell. 1987;48:549-554.
-
(1987)
Cell
, vol.48
, pp. 549-554
-
-
Hynes, R.O.1
-
2
-
-
0030873859
-
The aVb3 integrin "vitronectin receptor
-
Horton MA. The aVb3 integrin "vitronectin receptor." Int J Biochem Cell Biol. 1997;29:721-725.
-
(1997)
Int J Biochem Cell Biol
, vol.29
, pp. 721-725
-
-
Horton, M.A.1
-
3
-
-
0034698147
-
Ligand binding to integrins
-
DOI 10.1074/jbc.R000003200
-
Plow EF, Haas TA, Zhang L, Loftus J, Smith JW. Ligand binding to integrins. J Biol Chem. 2000;275:21785-21788. (Pubitemid 30621742)
-
(2000)
Journal of Biological Chemistry
, vol.275
, Issue.29
, pp. 21785-21788
-
-
Plow, E.F.1
Haas, T.A.2
Zhang, L.3
Loftus, J.4
Smith, J.W.5
-
4
-
-
0033121275
-
The role of αv integrins during angiogenesis: Insights into potential mechanisms of action and clinical development
-
Eliceiri BP, Cheresh DA. The role of alpha v integrins during angiogenesis: Insights into potential mechanisms of action and clinical development. J Clin Invest. 1999;103:1227-1230. (Pubitemid 29218291)
-
(1999)
Journal of Clinical Investigation
, vol.103
, Issue.9
, pp. 1227-1230
-
-
Eliceiri, B.P.1
Cheresh, D.A.2
-
5
-
-
0028670833
-
Integrin aVb3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
-
Brooks PC, Montgomery AM, Rosenfeld M, et al. Integrin aVb3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994;79:1157-1164.
-
(1994)
Cell
, vol.79
, pp. 1157-1164
-
-
Brooks, P.C.1
Montgomery, A.M.2
Rosenfeld, M.3
-
6
-
-
0023637601
-
New perspectives in cell adhesion: RGD and integrins
-
Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science. 1987;238:491-497. (Pubitemid 17147032)
-
(1987)
Science
, vol.238
, Issue.4826
, pp. 491-497
-
-
Ruoslahti, E.1
Pierschbacher, M.D.2
-
7
-
-
0032587186
-
3 integrin antagonists: A new class of tracers for tumor targeting
-
Haubner R,Wester HJ, Reuning U, et al. Radiolabeled aVb3 integrin antagonists: A new class of tracers for tumor targeting. J Nucl Med. 1999;40:1061-1071. (Pubitemid 29269229)
-
(1999)
Journal of Nuclear Medicine
, vol.40
, Issue.6
, pp. 1061-1071
-
-
Haubner, R.1
Wester, H.-J.2
Reuning, U.3
Senekowitsch-Schmidtke, R.4
Diefenbach, B.5
Kessler, H.6
Stocklin, G.7
Schwaiger, M.8
-
8
-
-
0142074845
-
Radiotracer-based strategies to image angiogenesis
-
Haubner R, Wester HJ, Weber WA, Schwaiger M. Radiotracer based strategies to image angiogenesis. Q J Nucl Med. 2003;47:189-199. (Pubitemid 37279155)
-
(2003)
Quarterly Journal of Nuclear Medicine
, vol.47
, Issue.3
, pp. 189-199
-
-
Haubner, R.1
Wester, H.J.2
Weber, W.A.3
Schwaiger, M.4
-
9
-
-
18244376347
-
Noninvasive visualization of the activated aVb3 integrin in cancer patients by positron emission tomography and [18F] galacto-RGD
-
Haubner R, Weber WA, Beer AJ, et al. Noninvasive visualization of the activated aVb3 integrin in cancer patients by positron emission tomography and [18F] galacto-RGD. PLoS Med. 2005;2:-70.
-
(2005)
PLoS Med
, vol.2
, pp. 70
-
-
Haubner, R.1
Weber, W.A.2
Beer, A.J.3
-
10
-
-
0035266374
-
18F-labeled RGD-containing glycopeptide and positron emission tomography
-
Haubner R, Wester HJ, Weber WA, et al. Noninvasive imaging of aVb3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res. 2001;61:1781-1785. (Pubitemid 32691983)
-
(2001)
Cancer Research
, vol.61
, Issue.5
, pp. 1781-1785
-
-
Haubner, R.1
Wester, H.J.2
Weber, W.A.3
Mang, C.4
Ziegler, S.I.5
Goodman, S.L.6
Senekowitsch-Schmidtke, R.7
Kessler, H.8
Schwaiger, M.9
-
11
-
-
25444503494
-
18F-Galacto-RGD in cancer patients
-
Beer AJ, Haubner R, Goebel M, et al. Biodistribution and pharmacokinetics of the aVb3-selective tracer 18F-galacto-RGD in cancer patients. J Nucl Med. 2005;46:1333-1341. (Pubitemid 43733484)
-
(2005)
Journal of Nuclear Medicine
, vol.46
, Issue.8
, pp. 1333-1341
-
-
Beer, A.J.1
Haubner, R.2
Goebel, M.3
Luderschmidt, S.4
Spilker, M.E.5
Wester, H.-J.6
Weber, W.A.7
Schwaiger, M.8
-
12
-
-
33746032220
-
3 expression in man
-
DOI 10.1158/1078-0432.CCR-06-0266
-
Beer AJ, Haubner R, Sarbia M, et al. Positron emission tomography using [18F] galacto-RGD identifies the level of integrin aVb3 expression in man. Clin Cancer Res. 2006;12:3942-3949. (Pubitemid 44078079)
-
(2006)
Clinical Cancer Research
, vol.12
, Issue.13
, pp. 3942-3949
-
-
Beer, A.J.1
Haubner, R.2
Sarbia, M.3
Goebel, M.4
Luderschmidt, S.5
Grosu, A.L.6
Schnell, O.7
Niemeyer, M.8
Kessler, H.9
Wester, H.-J.10
Weber, W.A.11
Schwaiger, M.12
-
13
-
-
53749107069
-
The biodistribution and radiation dosimetry of the Arg-Gly-Asp peptide 18F-AH111585 in healthy volunteers
-
McParland BJ, Miller MP, Spinks TJ, et al. The biodistribution and radiation dosimetry of the Arg-Gly-Asp peptide 18F-AH111585 in healthy volunteers. J Nucl Med. 2008;49:1664-1667.
-
(2008)
J Nucl Med
, vol.49
, pp. 1664-1667
-
-
McParland, B.J.1
Miller, M.P.2
Spinks, T.J.3
-
14
-
-
44849137859
-
18F-AH111585 in breast cancer patients
-
DOI 10.2967/jnumed.107.049452
-
Kenny LM, Coombes RC, Oulie I, et al. Phase I trial of the positron-emitting Arg-Gly-Asp peptide radioligand 18F-AH111585 in breast cancer patients. J Nucl Med. 2008;49:879-886. (Pubitemid 351793427)
-
(2008)
Journal of Nuclear Medicine
, vol.49
, Issue.6
, pp. 879-886
-
-
Kenny, L.M.1
Coombes, R.C.2
Oulie, I.3
Contractor, K.B.4
Miller, M.5
Spinks, T.J.6
McParland, B.7
Cohen, P.S.8
Hui, A.-M.9
Palmieri, C.10
Osman, S.11
Glaser, M.12
Turton, D.13
Al-Nahhas, A.14
Aboagye, E.O.15
-
15
-
-
33750701133
-
NC-100717: A versatile RGD peptide scaffold for angiogenesis imaging
-
DOI 10.1016/j.bmcl.2006.09.033, PII S0960894X06010821
-
Indrevoll B, Kindberg GM, Solbakken M, et al. NC-100717: A versatile RGD peptide scaffold for angiogenesis imaging. Bioorg Med Chem Lett. 2006;16: 6190-6193. (Pubitemid 44709917)
-
(2006)
Bioorganic and Medicinal Chemistry Letters
, vol.16
, Issue.24
, pp. 6190-6193
-
-
Indrevoll, B.1
Kindberg, G.M.2
Solbakken, M.3
Bjurgert, E.4
Johansen, J.H.5
Karlsen, H.6
Mendizabal, M.7
Cuthbertson, A.8
-
16
-
-
33750598987
-
99mTc-NC100692
-
Bach-Gansmo T, Danieleeon R, Saracco A, et al. Integrin receptor imaging of breast cancer: A proof-of-concept study to evaluate 99mTc-NC100692. J Nucl Med. 2006;47:1434-1439. (Pubitemid 47544928)
-
(2006)
Journal of Nuclear Medicine
, vol.47
, Issue.9
, pp. 1434-1439
-
-
Bach-Gansmo, T.1
Danielsson, R.2
Saracco, A.3
Wilczek, B.4
Bogsrud, T.V.5
Fangberget, A.6
Tangerud, A.7
Tobin, D.8
-
17
-
-
75649102481
-
An open-label, multi-center, phase 2a study to assess the feasibility of imaging metastases in late-stage cancer patients with the aVb3-selective angiogenesis imaging agent 99mTc-NC100692
-
Axelsson R, Bach-Gansmo T, Castell-Conesa J, McParland BJ. Study Group. An open-label, multi-center, phase 2a study to assess the feasibility of imaging metastases in late-stage cancer patients with the aVb3-selective angiogenesis imaging agent 99mTc-NC100692. Acta Radiol. 2010;51:40-46.
-
(2010)
Acta Radiol
, vol.51
, pp. 40-46
-
-
Axelsson, R.1
Bach-Gansmo, T.2
Castell-Conesa, J.3
McParland, B.J.4
-
18
-
-
58149096799
-
Improving tumor uptake and excretion kinetics of 99mTc-labeled cyclic arginine-glycine-aspartic (RGD) dimmers with triglycine linkers
-
Shi J, Wang L, Kim YS, et al. Improving tumor uptake and excretion kinetics of 99mTc-labeled cyclic arginine-glycine-aspartic (RGD) dimmers with triglycine linkers. J Med Chem. 2008;51:7980-7990.
-
(2008)
J Med Chem
, vol.51
, pp. 7980-7990
-
-
Shi, J.1
Wang, L.2
Kim, Y.S.3
-
19
-
-
77949845083
-
Tumor uptake of the RGD dimeric probe 99mTc-G3-2P4-RGD2 is correlated with integrin aVb3 expressed on both tumor cells and neovasculature
-
Liu Z, Jia B, Shi J, et al. Tumor uptake of the RGD dimeric probe 99mTc-G3-2P4-RGD2 is correlated with integrin aVb3 expressed on both tumor cells and neovasculature. Bioconjug Chem. 2010;21:548-555.
-
(2010)
Bioconjug Chem
, vol.21
, pp. 548-555
-
-
Liu, Z.1
Jia, B.2
Shi, J.3
-
20
-
-
80053040720
-
99mTc-labeled cyclic RGD peptides for noninvasive monitoring of tumor integrin aVb3 expression
-
Zhou Y, Kim YS, Chakraborty S, Shi J, Gao H, Liu S. 99mTc-labeled cyclic RGD peptides for noninvasive monitoring of tumor integrin aVb3 expression. Mol Imaging. 2011;10:386-397.
-
(2011)
Mol Imaging
, vol.10
, pp. 386-397
-
-
Zhou, Y.1
Kim, Y.S.2
Chakraborty, S.3
Shi, J.4
Gao, H.5
Liu, S.6
-
21
-
-
80052646479
-
Blood clearance kinetics, biodistribution, and radiation dosimetry of a kit-formulated integrin aVb3-selective radiotracer 99mTc-3PRGD2 in non-human primates
-
Jia B, Liu Z, Zhu Z, et al. Blood clearance kinetics, biodistribution, and radiation dosimetry of a kit-formulated integrin aVb3-selective radiotracer 99mTc-3PRGD2 in non-human primates. Mol Imaging Biol. 2011;13:730-736.
-
(2011)
Mol Imaging Biol
, vol.13
, pp. 730-736
-
-
Jia, B.1
Liu, Z.2
Zhu, Z.3
-
22
-
-
84856209326
-
Differential diagnosis of solitary pulmonary nodules using 99mTc-3P4-RGD2 scintigraphy
-
Ma Q, Ji B, Jia B, et al. Differential diagnosis of solitary pulmonary nodules using 99mTc-3P4-RGD2 scintigraphy. Eur J Nucl Med Mol Imaging. 2011;38: 2145-2152.
-
(2011)
Eur J Nucl Med Mol Imaging
, vol.38
, pp. 2145-2152
-
-
Ma, Q.1
Ji, B.2
Jia, B.3
-
23
-
-
0036930886
-
Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting
-
Janssen M, Oyen W, Massuger LF, et al. Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor imaging. Cancer Biother Radiopharm. 2002;17:641-646. (Pubitemid 36025945)
-
(2002)
Cancer Biotherapy and Radiopharmaceuticals
, vol.17
, Issue.6
, pp. 641-646
-
-
Janssen, M.1
Oyen, W.J.G.2
Massuger, L.F.A.G.3
Frielink, C.4
Dijkgraaf, I.5
Edwards, D.S.6
Radjopadhye, M.7
Corstens, F.H.M.8
Boerman, O.C.9
-
24
-
-
33846422759
-
3 integrin by multimerisation of RGD peptides
-
DOI 10.1007/s00259-006-0180-9
-
Dijkgraaf I, Kruijtzer JA, Liu S, et al. Improved targeting of the aVb3 integrin by multimerisation of RGD peptides. Eur J Nucl Med Mol Imaging. 2007;34:267-273. (Pubitemid 46147510)
-
(2007)
European Journal of Nuclear Medicine and Molecular Imaging
, vol.34
, Issue.2
, pp. 267-273
-
-
Dijkgraaf, I.1
Kruijtzer, J.A.W.2
Liu, S.3
Soede, A.C.4
Oyen, W.J.G.5
Corstens, F.H.M.6
Liskamp, R.M.J.7
Boerman, O.C.8
-
25
-
-
0037775714
-
Multimeric cyclic RGD peptides as potential tools for tumor targeting: Solid-phase peptide synthesis and chemoselective oxime ligation
-
Thumshirn G, Hersel U, Goodman SL, et al. Multimeric cyclic RGD peptides as potential tools for tumor targeting: Solid-phase peptide synthesis and chemoselective oxime ligation. Chemistry. 2003;9:2717-2725.
-
(2003)
Chemistry
, vol.9
, pp. 2717-2725
-
-
Thumshirn, G.1
Hersel, U.2
Goodman, S.L.3
-
26
-
-
1642533551
-
125I-labeled RGD peptide are improved by PEGylation
-
DOI 10.1016/j.nucmedbio.2003.07.003
-
Chen X, Park R, Shahinian AH, et al. Pharmacokinetics and tumor retention of 125Ilabeled RGD peptide are improved by PEGylation. Nucl Med Biol. 2004;31:11-19. (Pubitemid 38115121)
-
(2004)
Nuclear Medicine and Biology
, vol.31
, Issue.1
, pp. 11-19
-
-
Chen, X.1
Park, R.2
Shahinian, A.H.3
Bading, J.R.4
Conti, P.S.5
-
27
-
-
15044364765
-
18F-galacto-RGD
-
Pichler BJ, Kneilling M, Haubner R, et al. Imaging of delayed-type hypersensitivity reaction by PET and 18F-galacto-RGD. J Nucl Med. 2005;46:184-189. (Pubitemid 43086015)
-
(2005)
Journal of Nuclear Medicine
, vol.46
, Issue.1
, pp. 184-189
-
-
Pichler, B.J.1
Kneilling, M.2
Haubner, R.3
Braumuller, H.4
Schwaiger, M.5
Rocken, M.6
Weber, W.A.7
-
28
-
-
0038376001
-
Imaging of angiogenesis: From microscope to clinic
-
DOI 10.1038/nm0603-713
-
McDonald DM, Choyke PL. Imaging of angiogenesis: From microscope to clinic. Nat Med. 2003;9:713-725. (Pubitemid 36749220)
-
(2003)
Nature Medicine
, vol.9
, Issue.6
, pp. 713-725
-
-
McDonald, D.M.1
Choyke, P.L.2
|